Clinical Research Site

New York, New York 10128

4 studies enrolling now · 14 studies all time

What they study most

ADHD, Agitation in Patients With Dementia of the Alzheimer's Type, Agitation,Psychomotor, Alzheimer Disease, Binge-Eating Disorder, Hidradenitis Suppurativa, Major Depressive Disorder, Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms, Migraine, Pulmonary Aspergillosis, Scabies, Thyroid Eye Disease

Studies at this site

• Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol — Recruiting now
• Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol — Recruiting now
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms — Recruiting now
• An Open-label Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study) — Completed
• A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS) — Completed
• Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder — Enrolling by invitation
• Hidradenitis Suppurativa Study of Izokibep — Stopped early
• Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED) — Completed
• Hidradenitis Suppurativa Phase 2b Study of Izokibep — Completed
• Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis — Stopped early
• Assessing Clinical Outcomes in Alzheimer's Disease Agitation — Completed
• Maximizing Outcomes in Treating Acute Migraine — Completed
• A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies — Completed
• Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed